These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 35096599)
1. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer. Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X Front Oncol; 2021; 11():799223. PubMed ID: 35096599 [TBL] [Abstract][Full Text] [Related]
2. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J Front Genet; 2021; 12():661306. PubMed ID: 34249086 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related]
5. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis. Chen Q; Hu L; Chen K Front Genet; 2020; 11():570325. PubMed ID: 33193668 [TBL] [Abstract][Full Text] [Related]
6. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer. Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672 [No Abstract] [Full Text] [Related]
7. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data. Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes. Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791 [No Abstract] [Full Text] [Related]
9. An Han Y; Wong FC; Wang D; Kahlert C Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555 [TBL] [Abstract][Full Text] [Related]
10. Identification of an EMT-related gene-based prognostic signature in osteosarcoma. Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
13. A novel pyroptosis gene expression-based risk score for survival in gastric cancer. Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel inflammatory-related gene signature to evaluate the prognosis of gastric cancer patients. Hu JL; Huang MJ; Halina H; Qiao K; Wang ZY; Lu JJ; Yin CL; Gao F World J Gastrointest Oncol; 2024 Mar; 16(3):945-967. PubMed ID: 38577477 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer. Zeng Z; Xie D; Gong J PeerJ; 2020; 8():e9624. PubMed ID: 32821544 [TBL] [Abstract][Full Text] [Related]
16. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Lin Z; Xu Q; Miao D; Yu F Front Oncol; 2021; 11():644416. PubMed ID: 33828988 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer. Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W Front Oncol; 2022; 12():863094. PubMed ID: 35619909 [TBL] [Abstract][Full Text] [Related]
18. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D Front Genet; 2022; 13():965033. PubMed ID: 36186426 [No Abstract] [Full Text] [Related]
19. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. Huang S; Li D; Zhuang L; Zhang J; Wu J Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]